MediRelief Hot Patch Capsaicin 0.025%
- Manufacturer
- Farla Medical Healthcare LTD
- Effective date
- 2024-02-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:10:53
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Drug Facts
Active ingredient & Purpose
OTC - PURPOSE SECTION
Active ingredients(in each patch) | Purpose |
Capsaicin 0.025%........................................................................................................................................................ | Topical analgesic |
Uses
For the temporary relief of minor aches and pains of muscles and joints associated with
- simple back aches
- arthritis
- strains
- sprains
Warnings
FOR EXTERNAL USE ONLY. Avoid contact with the eyes.
Do not use
- on wounds or damaged skin
- on a tight bandage
- with a heating pad
- on sensitive skin
- if allergic to any ingredients in this product
Stop use and ask a doctor if
- condition worsens
- symptoms persist for more than 7 days or clear up and occur again within a few days
If pregnant or breast-feeding,
ask a health professional before use.
KEEP OUT OF REACH OF CHILDREN.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- adults & children 12 years of age and older: apply to affected area not more than 3 to 4 times daily
- children under 12 years of age: consult a doctor
Other information
- store at room temperature 68-77°F (20-25°C)
- do not store in direct sunlight or expose to excessive heat and moisture
TAMPER EVIDENT: Do not use if pouch containing the patch is torn or broken.
Inactive ingredients
hydrogenated poly (C6-20 olefin), mineral oil, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, styrene/isoprene copolymer
Manufactured for & Distributed by:
Manufactured for:
Farla International Ltd., Unit 2,
Staples Corner Business Park, 1000 North Circular Road,
London NW2 7JP
Tel +1 (844) 280-8400
sales@farlainternational.com -
www.farlainternational.com
Distributed by:
Platinum Care
240 52nd Street, Brooklyn, NY 11220
Tel: +1-718-435-2072
Pricipal Display Panel
MediRelief a Farla brand
Hot
Penetrating Pain
Relief Patch
Capsaicin 0.025%
TEMPORARY RELIEF OF
MINOR ACHES AND PAINS:
• ARTHRITIS
• BACKACHES
• SPRAINS
• STRAINS
1 Patch
(Large)
5.1 in. x 7.1 in.
(13 cm x 18 cm)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73486-100-35 | 2024-02-26 | C162847 | 48780-1 | 1030e365-07fd-111a-e063-dadaa90a10e2 | MediRelief Hot Patch Capsaicin 0.025% |
| 73486-100-35 | 2024-01-30 | C162847 | 48780-1 | 1030e365-07fd-111a-e063-dadaa90a10e2 | MediRelief Hot Patch Capsaicin 0.025% |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- MediRelief Hot
- Capsaicin
- MINERAL OIL
- PENTAERYTHRITOL 3,5-DI-TERT-BUTYL-4-HYDROXYHYDROCINNAMATE
- STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER
- HYDROGENATED C6-20 POLYOLEFIN (100 CST)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 73486-100 | 73486-100-35 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAPSAICIN | S07O44R1ZM | ACTIB |
| MINERAL OIL | T5L8T28FGP | IACT |
| PENTAERYTHRITOL 3,5-DI-TERT-BUTYL-4-HYDROXYHYDROCINNAMATE | A8VXR0397K | IACT |
| STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER | K7S96QM8DV | IACT |
| HYDROGENATED C6-20 POLYOLEFIN (100 CST) | 39EYQ1W9RB | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46a1f235-544c-2157-e063-6294a90a3dd5 | 9a545ec8-009f-edd3-e053-2a95a90aa7bb | 2025-12-23 | Warnings | 9a545ec8-009f-edd3-e053-2a95a90aa7bb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
